Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21363| Title: | Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adenocarcinoma/*drug therapy,Adult,Aged,Antineoplastic Agents/*administration & dosage/adverse effects/pharmacokinetics,Disease Progression,Disease-Free Survival,Female,Glucose/analogs & derivatives,Humans,Ifosfamide/analogs & derivatives,Infusions, Intravenous,Male,Middle Aged,Pancreatic Neoplasms/*drug therapy,Phosphoramide Mustards/*administration & dosage/adverse effects/pharmacokinetics,Prospective Studies,Treatment Outcome |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/21363 |
| ISSN: | 0959-8049 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/14556925 http://ac.els-cdn.com/S0959804903006294/1-s2.0-S0959804903006294-main.pdf?_tid=05b9b2b6ce8eed635fd141cf9fb66f09&acdnat=1333702811_8b856e6815e294d62b882fbb20543193 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Briasoulis-2003-Glufosfamide adminis.pdf | 218.17 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
